(1R,2R)-2-[4-(3-메틸-1H-피라졸-5-일)벤조일]-N-(4-옥소-4,5,6,7-테트라하이드로피라졸로[1,5-A]피라진-3-일)사이클로헥산카복스아미드의 결정형

(1,2)-2-[4-(3-메틸-1-피라졸-5-일)벤조일]--(4-옥소-4,5,6,7-테트라하이드로피라졸로[1,5-]피라진-3-일)사이클로헥산카복스아미드의 결정형, 그를 함유하는 약제학적 조성물 및 치료법에서의 그의 용도. A crystalline form of (1R,2R)-2-[4-(3-Methyl-1H-pyrazol-5-yl)benzoyl]-N-(4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-3-yl)cyclohexanecarboxamide, pharmaceutical compositions...

Full description

Saved in:
Bibliographic Details
Main Author PETTERSEN ANNA MATILDA ANGELICA
Format Patent
LanguageKorean
Published 24.06.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract (1,2)-2-[4-(3-메틸-1-피라졸-5-일)벤조일]--(4-옥소-4,5,6,7-테트라하이드로피라졸로[1,5-]피라진-3-일)사이클로헥산카복스아미드의 결정형, 그를 함유하는 약제학적 조성물 및 치료법에서의 그의 용도. A crystalline form of (1R,2R)-2-[4-(3-Methyl-1H-pyrazol-5-yl)benzoyl]-N-(4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-3-yl)cyclohexanecarboxamide, pharmaceutical compositions containing it and its use in the prevention or treatment of cardiovascular diseases.
AbstractList (1,2)-2-[4-(3-메틸-1-피라졸-5-일)벤조일]--(4-옥소-4,5,6,7-테트라하이드로피라졸로[1,5-]피라진-3-일)사이클로헥산카복스아미드의 결정형, 그를 함유하는 약제학적 조성물 및 치료법에서의 그의 용도. A crystalline form of (1R,2R)-2-[4-(3-Methyl-1H-pyrazol-5-yl)benzoyl]-N-(4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-3-yl)cyclohexanecarboxamide, pharmaceutical compositions containing it and its use in the prevention or treatment of cardiovascular diseases.
Author PETTERSEN ANNA MATILDA ANGELICA
Author_xml – fullname: PETTERSEN ANNA MATILDA ANGELICA
BookMark eNrjYmDJy89L5WTYpGEYpGMUpKlrpBttoqthrPt65ZS33Tt0DT10307Z83runjcLd-ia6r6Zu0fz9aYlbxZuALJidf10NUx038xY-qatR9dEx1THTMdc921rz9uuHUAdb6fOeDN3y-vJc14vnAM3A8iONtQx1XWMhQotb9E1Bhv7pmkNUPnbxi0g5dOXvmna8Gbnltebt77pWvJmasvr9TuAJr2ZO0Ph1aYNbxZMfTtjKg8Da1piTnEqL5TmZlB2cw1x9tBNLciPTy0uSExOzUstifcOMjIwtDQwMDc0NzV3NCZOFQB8T4LZ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20190071757A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20190071757A3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:08:20 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20190071757A3
Notes Application Number: KR20197014045
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190624&DB=EPODOC&CC=KR&NR=20190071757A
ParticipantIDs epo_espacenet_KR20190071757A
PublicationCentury 2000
PublicationDate 20190624
PublicationDateYYYYMMDD 2019-06-24
PublicationDate_xml – month: 06
  year: 2019
  text: 20190624
  day: 24
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies ASTRAZENECA AB
RelatedCompanies_xml – name: ASTRAZENECA AB
Score 3.1691482
Snippet (1,2)-2-[4-(3-메틸-1-피라졸-5-일)벤조일]--(4-옥소-4,5,6,7-테트라하이드로피라졸로[1,5-]피라진-3-일)사이클로헥산카복스아미드의 결정형, 그를 함유하는 약제학적 조성물 및 치료법에서의 그의 용도. A crystalline form of...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title (1R,2R)-2-[4-(3-메틸-1H-피라졸-5-일)벤조일]-N-(4-옥소-4,5,6,7-테트라하이드로피라졸로[1,5-A]피라진-3-일)사이클로헥산카복스아미드의 결정형
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190624&DB=EPODOC&locale=&CC=KR&NR=20190071757A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTZMTUs1N0_TtUxJNdM1AeYmXWClZ6xrYp5obJFoYZ5olAheIOtn5hFq4hVhGsHEkAPbCwM-J7QcfDgiMEclA_N7Cbi8LkAMYrmA11YW6ydlAoXy7d1CbF3UoL1jQ9CpuyZqLk62rgH-Lv7Oas7Ott5Ban5BEDlQ38XU3JGZgRXYkDYH5QfXMCfQvpQC5ErFTZCBLQBoXl6JEANTdr4wA6cz7O41YQYOX-iUN5AJzX3FIgybNAyDdIyCNHWNdKNNdDWMdV-vnPK2e4euoYfu2yl7Xs_d82bhDl1T3Tdz92i-3rTkzcINQFasrp-uhonumxlL37T16JromOqY6Zjrvm3tedu1A6jj7dQZb-ZueT15zuuFc-BmANnRhjqmuo6xUKHlLbrGYGPfNK0BKn_buAWkfPrSN00b3uzc8nrz1jddS95MbXm9fgfQpDdzZyi82rThzYKpb2dMFWVQdnMNcfbQBXo-Hh7W8d5ByCFlLMbAkpeflyrBoJCYmmJhkmZuYJRmYmYCapUkmpunGCUbGCYCo9TE0kSSQQafSVL4paUZuEBc0BosIxMZBpaSotJUWWBtX5IkB44kABKz1lY
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTZMTUs1N0_TtUxJNdM1AeYmXWClZ6xrYp5obJFoYZ5olAheIOtn5hFq4hVhGsHEkAPbCwM-J7QcfDgiMEclA_N7Cbi8LkAMYrmA11YW6ydlAoXy7d1CbF3UoL1jQ9CpuyZqLk62rgH-Lv7Oas7Ott5Ban5BEDlQ38XU3JGZgRXYyDYH5QfXMCfQvpQC5ErFTZCBLQBoXl6JEANTdr4wA6cz7O41YQYOX-iUN5AJzX3FIgybNAyDdIyCNHWNdKNNdDWMdV-vnPK2e4euoYfu2yl7Xs_d82bhDl1T3Tdz92i-3rTkzcINQFasrp-uhonumxlL37T16JromOqY6Zjrvm3tedu1A6jj7dQZb-ZueT15zuuFc-BmANnRhjqmuo6xUKHlLbrGYGPfNK0BKn_buAWkfPrSN00b3uzc8nrz1jddS95MbXm9fgfQpDdzZyi82rThzYKpb2dMFWVQdnMNcfbQBXo-Hh7W8d5ByCFlLMbAkpeflyrBoJCYmmJhkmZuYJRmYmYCapUkmpunGCUbGCYCo9TE0kSSQQafSVL4peUZOD1CfH3ifTz9vKUZuEBSoPVYRiYyDCwlRaWpssCavyRJDhxhAE9M2Uk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=%281R%2C2R%29-2-%5B4-%283-%EB%A9%94%ED%8B%B8-1H-%ED%94%BC%EB%9D%BC%EC%A1%B8-5-%EC%9D%BC%29%EB%B2%A4%EC%A1%B0%EC%9D%BC%5D-N-%284-%EC%98%A5%EC%86%8C-4%2C5%2C6%2C7-%ED%85%8C%ED%8A%B8%EB%9D%BC%ED%95%98%EC%9D%B4%EB%93%9C%EB%A1%9C%ED%94%BC%EB%9D%BC%EC%A1%B8%EB%A1%9C%5B1%2C5-A%5D%ED%94%BC%EB%9D%BC%EC%A7%84-3-%EC%9D%BC%29%EC%82%AC%EC%9D%B4%ED%81%B4%EB%A1%9C%ED%97%A5%EC%82%B0%EC%B9%B4%EB%B3%B5%EC%8A%A4%EC%95%84%EB%AF%B8%EB%93%9C%EC%9D%98+%EA%B2%B0%EC%A0%95%ED%98%95&rft.inventor=PETTERSEN+ANNA+MATILDA+ANGELICA&rft.date=2019-06-24&rft.externalDBID=A&rft.externalDocID=KR20190071757A